Medibank Private Ltd (ASX: MPL)Similarly, Credit Suisse analysts expect strong premium growth to underpin Medibank’s recent turnaround in penetration rates. The broker believes the company could see earnings upgrades in the near-term.Medibank shares are rated as outperform with a $3.25 target price, which is around 12% higher than Tuesday’s closing share price.
- Forums
- ASX - By Stock
- MPL
- Credit Suisse Outperform
MPL
medibank private limited
Add to My Watchlist
0.79%
!
$5.00

Credit Suisse Outperform
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.00 |
Change
-0.040(0.79%) |
Mkt cap ! $13.77B |
Open | High | Low | Value | Volume |
$5.01 | $5.03 | $4.98 | $22.86M | 4.579M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3900 | $4.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.01 | 4612 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3900 | 4.990 |
5 | 8025 | 4.980 |
3 | 43998 | 4.970 |
2 | 24275 | 4.960 |
4 | 4395 | 4.950 |
Price($) | Vol. | No. |
---|---|---|
5.010 | 4612 | 2 |
5.020 | 8388 | 2 |
5.030 | 5500 | 2 |
5.040 | 1835 | 2 |
5.070 | 628 | 1 |
Last trade - 16.10pm 11/08/2025 (20 minute delay) ? |
Featured News
MPL (ASX) Chart |
The Watchlist
WIN
WIN METALS LTD
Steve Norregard, CEO & MD
Steve Norregard
CEO & MD
SPONSORED BY The Market Online